Immunobiology and Cancer Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America.
PLoS One. 2011 May 10;6(5):e19890. doi: 10.1371/journal.pone.0019890.
iNKT cells derive from CD4(+)CD8(+) DP thymocytes, and are selected by thymocyte-thymocyte interactions through signals from their invariant Vα14-Jα18 TCR and from the costimulatory molecules SLAMF1 and SLAMF6. Genetic studies have demonstrated the contribution of different signaling pathways to this process. Surprisingly, current models imply that the Ras/MAPK pathway, one of the critical mediators of conventional αβ T cell positive selection, is not necessary for iNKT cell development. Using mice defective at different levels of this pathway our results refute this paradigm, and demonstrate that Ras, and its downstream effectors Egr-1 and Egr-2 are required for positive selection of iNKT cells. Interestingly our results also show that there are differences in the contributions of several of these molecules to the development of iNKT and conventional αβ T cells.
iNKT 细胞来源于 CD4(+)CD8(+) DP 胸腺细胞,通过其不变的 Vα14-Jα18 TCR 和共刺激分子 SLAMF1 和 SLAMF6 与胸腺细胞-胸腺细胞之间的相互作用进行选择。遗传研究表明,不同的信号通路对这一过程有贡献。令人惊讶的是,目前的模型表明,Ras/MAPK 通路是传统 αβ T 细胞阳性选择的关键介质之一,对于 iNKT 细胞的发育不是必需的。使用该通路在不同水平上有缺陷的小鼠,我们的结果反驳了这一范例,并表明 Ras 及其下游效应物 Egr-1 和 Egr-2 对于 iNKT 细胞的阳性选择是必需的。有趣的是,我们的结果还表明,这些分子中的几个对 iNKT 和传统 αβ T 细胞的发育有不同的贡献。